Companion Diagnostics
SKU
MRR-433AB1DC2871
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 2.62 billion
2030
USD 5.63 billion
2024
USD 2.92 billion
CAGR
11.55%

Companion Diagnostics Market by Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing), Indication (Breast Cancer, Colorectal Cancer, Leukemia), End-User - Global Forecast 2024-2030

[180 Pages Report] The Companion Diagnostics Market size was estimated at USD 2.62 billion in 2023 and expected to reach USD 2.92 billion in 2024, at a CAGR 11.55% to reach USD 5.63 billion by 2030.

Companion Diagnostics Market
To learn more about this report, request a free PDF copy
Companion Diagnostics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Companion Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Companion Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abnova Corporation, Agilent Technologies, Inc., Almac Group, Amoy Diagnostics Co., Ltd., Archerdx, Inc., ARUP Laboratories, Biogenex Laboratories, Inc, bioMérieux SA, Danaher Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, Foundation Medicine, Inc., Guardant Health, Inc, Illumina, Inc., Invivoscribe Technologies, Inc., Myriad Genetics, Inc., NG biotech, R-Biopharm AG, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Companion Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Immunohistochemistry
    • In Situ Hybridization
    • Next-Generation Sequencing
    • Polymerase Chain Reaction
  • Indication
    • Breast Cancer
    • Colorectal Cancer
    • Leukemia
    • Lung Cancer
    • Melanoma
  • End-User
    • Biopharmaceutical Companies
    • Pharmaceutical
    • Reference Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Companion Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Companion Diagnostics Market?
  4. What is the market share of the leading vendors in the Companion Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Companion Diagnostics Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Growing significance of companion diagnostics in drug development
        2. Increasing demand for personalized medicines and targeted therapy
        3. Rise in R&D for development of next generation sequencing
      2. Restraints
        1. High costs of companion diagnostics
      3. Opportunities
        1. Technological advancements in diagnostic techniques
        2. Growing approval rate for companion diagnostics
      4. Challenges
        1. Reimbursement issues associated with companion diagnostic tests
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Companion Diagnostics Market, by Technology
    1. Introduction
    2. Immunohistochemistry
    3. In Situ Hybridization
    4. Next-Generation Sequencing
    5. Polymerase Chain Reaction
  7. Companion Diagnostics Market, by Indication
    1. Introduction
    2. Breast Cancer
    3. Colorectal Cancer
    4. Leukemia
    5. Lung Cancer
    6. Melanoma
  8. Companion Diagnostics Market, by End-User
    1. Introduction
    2. Biopharmaceutical Companies
    3. Pharmaceutical
    4. Reference Laboratories
  9. Americas Companion Diagnostics Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Companion Diagnostics Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Companion Diagnostics Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. COMPANION DIAGNOSTICS MARKET RESEARCH PROCESS
    2. COMPANION DIAGNOSTICS MARKET SIZE, 2023 VS 2030
    3. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. COMPANION DIAGNOSTICS MARKET DYNAMICS
    7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
    8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
    10. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    12. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. COMPANION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
    22. COMPANION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 292]
    1. COMPANION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    8. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    9. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    18. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    19. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY MELANOMA, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    30. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    31. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL COMPANION DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
    37. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    38. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    39. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    40. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    41. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    42. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    43. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    44. AMERICAS COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    45. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    46. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    47. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    48. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    49. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    50. ARGENTINA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    51. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    52. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    53. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    54. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    55. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    56. BRAZIL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    57. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    58. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    59. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    60. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    61. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    62. CANADA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    63. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    64. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    65. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    66. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    67. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    68. MEXICO COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    69. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    70. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    71. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    72. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    73. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    74. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    75. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    76. UNITED STATES COMPANION DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    77. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    78. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    79. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    80. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    81. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    82. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    83. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    84. ASIA-PACIFIC COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    85. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    86. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    87. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    88. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    89. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    90. AUSTRALIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    91. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    92. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    93. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    94. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    95. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    96. CHINA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    97. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    98. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    99. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    100. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    101. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    102. INDIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    103. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    104. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    105. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    106. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    107. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    108. INDONESIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    109. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    110. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    111. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    112. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    113. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    114. JAPAN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    115. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    116. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    117. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    118. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    119. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    120. MALAYSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    121. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    122. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    123. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    124. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    125. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    126. PHILIPPINES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    127. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    128. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    129. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    130. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    131. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    132. SINGAPORE COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    133. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    134. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    135. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    136. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    137. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    138. SOUTH KOREA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    139. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    140. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    141. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    142. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    143. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    144. TAIWAN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    145. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    146. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    147. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    148. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    149. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    150. THAILAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    151. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    152. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    153. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    154. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    155. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    156. VIETNAM COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    157. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    158. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    159. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    160. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    161. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    162. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    163. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    164. EUROPE, MIDDLE EAST & AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    165. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    166. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    167. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    168. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    169. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    170. DENMARK COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    171. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    172. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    173. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    174. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    175. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    176. EGYPT COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    177. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    178. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    179. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    180. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    181. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    182. FINLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    183. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    184. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    185. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    186. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    187. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    188. FRANCE COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    189. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    190. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    191. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    192. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    193. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    194. GERMANY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    195. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    196. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    197. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    198. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    199. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    200. ISRAEL COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    201. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    202. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    203. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    204. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    205. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    206. ITALY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    207. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    208. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    209. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    210. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    211. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    212. NETHERLANDS COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    213. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    214. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    215. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    216. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    217. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    218. NIGERIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    219. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    220. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    221. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    222. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    223. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    224. NORWAY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    225. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    226. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    227. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    228. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    229. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    230. POLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    231. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    232. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    233. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    234. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    235. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    236. QATAR COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    237. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    238. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    239. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    240. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    241. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    242. RUSSIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    243. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    244. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    245. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    246. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    247. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    248. SAUDI ARABIA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    249. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    250. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    251. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    252. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    253. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    254. SOUTH AFRICA COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    255. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    256. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    257. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    258. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    259. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    260. SPAIN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    261. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    262. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    263. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    264. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    265. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    266. SWEDEN COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    267. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    268. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    269. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    270. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    271. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    272. SWITZERLAND COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    273. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    274. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    275. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    276. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    277. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    278. TURKEY COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    279. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    280. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    281. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    282. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    283. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    284. UNITED ARAB EMIRATES COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    285. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    286. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    287. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    288. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    289. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    290. UNITED KINGDOM COMPANION DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    291. COMPANION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
    292. COMPANION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 21]
    1. Abbott Laboratories
    2. Abnova Corporation
    3. Agilent Technologies, Inc.
    4. Almac Group
    5. Amoy Diagnostics Co., Ltd.
    6. Archerdx, Inc.
    7. ARUP Laboratories
    8. Biogenex Laboratories, Inc
    9. bioMérieux SA
    10. Danaher Corporation
    11. Eli Lilly and Company
    12. F. Hoffmann-La Roche AG
    13. Foundation Medicine, Inc.
    14. Guardant Health, Inc
    15. Illumina, Inc.
    16. Invivoscribe Technologies, Inc.
    17. Myriad Genetics, Inc.
    18. NG biotech
    19. R-Biopharm AG
    20. Sysmex Corporation
    21. Thermo Fisher Scientific Inc.
Frequently Asked Questions
  1. How big is the Companion Diagnostics Market?
    Ans. The Global Companion Diagnostics Market size was estimated at USD 2.62 billion in 2023 and expected to reach USD 2.92 billion in 2024.
  2. What is the Companion Diagnostics Market growth?
    Ans. The Global Companion Diagnostics Market to grow USD 5.63 billion by 2030, at a CAGR of 11.55%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.